References
- Strickler RC. Dysfunctional uterine bleeding: diagnosis and treatment. Postgrad Med 1979: 66(5): 135–46
- Strickler RC. Tubal ligation syndrome: does it exist? Postgrad Med 1984: 75(1): 233–7
- Skjodt P, Albrechtsen OK. Coagulation and fibrinolysis in uterine blood. Acta Obstet Gynecol Scand 1965: 44: 416–36
- Rybo G. Plasminogen activators in the endometrium. II. Clinical aspects: variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet Gynecol Scand 1966: 45(4): 429–50
- Nilsson L, Rybo G. Treatment of menorrhagia with epsilon aminocaproic acid: a double blind investigation. Acta Obstet Gynecol Scand 1965: 44(3): 467–73
- Herxheimer A, Capel LH, ed. Aminocaproic acid in haemophilia and in menorrhagia. Drug Ther Bull 1967: 5: 63–4
- Downie J, Poyser NL, Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. J Physiol (Lond) 1974: 236(2): 465–72
- Abel MH, Baird DT. The effect of 17 beta-estradiol and progesterone on prostaglandin production by human endometrium maintained in organ culture. Endocrinology 1980: 106(5): 1599–606
- Anderson AB, Haynes PJ, Guillebaud J, et al. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Lancet 1976: 1(7963): 774–6
- Smith SK, Abel MH, Kelly RW, et al. A role for prostacyclin (PGI2) in excess menstrual bleeding. Lancet 1981: 1(8219): 522–4
- Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971: 110(5): 713–20
- Lithgow DM, Politzer WM. Vitamin A in the treatment of menorrhagia. S Afr Med J 1977: 51(7): 191–3
- Taymor ML, Sturgis SH, Yahia C. The etiologic role of chronic Iron deficiency in production of menorrhagia. JAMA 1964: 187(Feb 1): 323–7
- Smith JB, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971: 231 (Jun 23): 235–7
- Rosenwaks Z, Jones GS, Henzl MR, et al. Naproxen sodium, aspirin, and placebo in primary dysmenorrhea: reduction of pain and blood levels of prostaglandin F2-alpha metabolite. Am J Obstet Gynecol 1981: 140(5): 592–8
- Roy S. Shaw ST Jr. Role of prostaglandins in IUD-associated uterine bleeding: effect of a prostaglandin synthetase inhibitor (ibuprofen). Obstet Gynecol 1981: 58(1): 101–6
- Davies AJ, Anderson AB, Turnbull AC. Reduction of naproxen of excessive menstrual bleeding in women using intrauterine devices. Obstet Gynecol 1981: 57(1): 74–8
- Jones HW Jr, Jones GS. Novak's textbook of gynecology. 3rd ed. Baltimore: Williams & Wilkins, 1981: 478
- Chan WY, Dawood MY. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Adv Prostaglandin Thromboxane Leukotriene Res 1980: 8: 1443–7
- Kasonde JM, Bonnar J. Aminocaproic add and menstrual loss in women using intrauterine devises. Br Med J 1975: 4(5987): 17–9
- Chimbira TH, Anderson AB, Cope E, et al. Preliminary results on clinical and endocrine studies in the treatment of menorrhagia with danazol. Postgrad Med J 1979: 55(Suppl 5): 90–4
- Chimbira TH, Anderson AB, Naish C, et al. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol 1980: 87(12): 1152–8
- Goldrath MH, Fuller TA, Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol 1981: 140(1): 14–9